See at
https://youtu.be/n3w076epkK4Description
Researchers at the University of Maryland School of Medicine (UMSOM) have begun participation in the Phase 3 clinical trial of an investigational COVID-19 vaccine co-developed by scientists at Moderna Inc. and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Video includes brief interview with UMB President, Bruce E. Jarrell, MD, FACS, who is a participant in the trial.Keyword
Coronavirus Disease 2019 (COVID-19)Moderna
COVID-19 (Disease)
National Institute of Allergy and Infectious Diseases (U.S.)
University of Maryland, Baltimore. School of Medicine
Clinical Trial, Phase III
COVID-19 Vaccines